Construct Validation of PROMIS Short Form and Profile-29 T-Scores with SF-36 in Rheumatoid Arthritis Patients Treated for 1 Year: Results from a Real World Evidence-Based Study in the United States

被引:0
|
作者
Bingham, Clifton [1 ]
Kafka, Shelly [2 ]
Black, Shawn [3 ]
Xu, Stephen [4 ]
Curtis, Jeffrey [5 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Janssen Sci Affairs LLC, Horsham, PA USA
[3] Janssen Sci Affairs LLC, Horsham, RI USA
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1365
引用
收藏
页数:3
相关论文
共 2 条
  • [1] CONSTRUCT VALIDATION OF PROMIS SHORT FORM AND PROFILE-29 T-SCORES WITH SF-36 IN RHEUMATOID ARTHRITIS PATIENTS TREATED FOR 1 YEAR: RESULTS FROM A REAL-WORLD EVIDENCE-BASED STUDY IN THE UNITED STATES
    Bingham, C.
    Kafka, S.
    Black, S.
    Xu, S.
    Langholff, W.
    Curtis, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 882 - 882
  • [2] UNITED STATES RHEUMATOLOGY PRACTICE BASED REAL-WORLD EVIDENCE OF METHOTREXATE UTILIZATION AND RESPONSE TO THERAPY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INTRAVENOUS GOLIMUMAB: 52-WEEK FROM THE AWARE STUDY
    Broadwell, Aaron
    Schechtman, Joy
    Conaway, Douglas
    Kivitz, Alan
    Black, Shawn
    Xu, Stephen
    Langholff, Wayne
    Zazzetti, Federico
    Kafka, Shelly
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 82 - 82